PRNews: Biotech

PR Newswire: Biotechnology

Press Releases from PR Newswire about Biotechnology

China Sky One Medical Updates Financial Guidance for 2010

HARBIN, China, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that its fiscal year 2010 revenue and adjusted
 

Maryland Stem Cell Research Commission to Host Third Annual Maryland Stem Cell Research Symposium

COLUMBIA, Md., Sept. 3 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) will host the Third Annual Maryland Stem Cell Research Symposium in partnership with the National Institutes of Health (NIH) and the National Institute of Standards and Technology (NIST) on Wednesday, Sept
 

China-Biotics Announces September 20 Investor Day Schedule

SHANGHAI, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced the schedule for the Investor Day, which will be held on Monday, September 20
 

Medical Affairs Report Outlines Resource Needs for Group Success

CHAPEL HILL, N.C., Sept. 3 /PRNewswire/ -- The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization, with heavy responsibilities across areas such as clinical development, scientific publications, KOL development, and medical education. These areas must
 

Waters Corporation and UCLA to Convene Leading Life Scientists

MILFORD, Mass., Sept. 3 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and the University of California at Los Angeles (UCLA) will bring together some of the world's leading life science researchers and practitioners of mass spectrometry (MS) at a conference next month to discuss the ways they are a
 

China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results

HONG KONG, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO; "the Company") today announced its plan to release financial results for the first quarter of fiscal year 2011 on Friday, September 10, 2010, before the market opens in the US. The Company will hold a
 

Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278

CORK, Ireland, September 3, 2010 /PRNewswire/ -- Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibi
 

The Female Health Company to Present at Rodman & Renshaw's Annual Global Investment Conference on Wednesday, September 15, 2010

CHICAGO, Sept. 3 /PRNewswire/ -- The Female Health Company (Nasdaq: FHCO), which manufactures and markets the FC2 Female Condom®, today announced that the Company's CEO, O.B. Parrish, and its CFO, Donna Felch, are scheduled to make a presentation at Rodman & Renshaw's Global Investment Conf
 

ForteBio Announces Launch of Protein G Biosensor for Use on Company's Octet® Instruments

MENLO PARK, Calif., Sept. 3 /PRNewswire/ -- ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Dip and Read™ Protein G biosensor for rapid detection and quantificati
 

New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets

DALLAS, Texas, September 3, 2010 /PRNewswire/ -- Buy this report now: http://www.marketsandmarkets.com/Market-Reports/digestive-health-ingredients- 225.html (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. R
 

American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling

BETHESDA, Md., Sept. 2 /PRNewswire-USNewswire/ -- The American Society for Biochemistry and Molecular Biology expressed its disapproval and disappointment this week in response to the Aug. 23 ruling in the U.S. District Court for the District of Columbia that granted a preliminary injunction barring
 

Sequenom to Present at Two Financial Conferences in September

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Ronald M. Lindsay, PhD, executive vice president of research and development, will present an overview of the company at the following conferences in September. (Logo:  http://photos.prnewswire.com/p

 

Celsion Receives SBIR Grant To Expand Its Technology Platform

COLUMBIA, Md., Sept. 2 /PRNewswire-FirstCall/ --Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support th
 

Sales Success Shows Neuromarketing Moves Magazines: New Scientist Reports 12% Increase in Newsstand Sales for Issue Featuring NeuroFocus-Tested Cover Design

LONDON , Sept. 2 /PRNewswire/ -- For marketers everywhere, especially consumer goods companies for whom packaging is a critical determinant of success, the question asked has now been definitively answered: neuromarketing can increase sales—substantially. When New Scientist approached NeuroFoc
 

Mark S. Rangell Appointed Chief Operating Officer for Sandata Technologies, LLC

PORT WASHINGTON, N.Y., Sept. 2 /PRNewswire/ -- Sandata Technologies, LLC, a leading national provider of information technology solutions to the home healthcare community, today announced the hiring of Mark S. Rangell as its Chief Operating Officer. Mr. Rangell will be in charge of Sandata's day-to-
 

Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010

LAUSANNE, Switzerland, September 2, 2010 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, today announced that the 'Debiopharm Life Scienc
 

Statement From Sicel Technologies, Inc.

RALEIGH, N.C., Sept. 2 /PRNewswire/ -- Sicel Technologies, Inc., announced today that the organization has not been placed into involuntary bankruptcy. Effective August 31, 2010, Paul McDaniel became the interim President and an interim Director of the company. Currently, Sicel's operations are cont
 

AloeSafeâ„¢ Hand Sanitizer is Free From Toxic Chemicals

SANTA MARIA, Calif., Sept. 2 /PRNewswire/ -- Hardy Diagnostics, an FDA licensed and ISO certified biomedical firm, is pleased to announce the release of AloeSafe™, a hand sanitizer that contains aloe vera, vitamin E, and lavender oil. Unlike most alcohol based hand sanitizers, AloeSafe™

 

Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development

CARY, N.C., Sept. 2 /PRNewswire/ -- Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the late
 

New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments

SHENZHEN, China, Sept. 2 /PRNewswire-Asia/ -- In a new peer-reviewed article published by the Journal of Translational Medicine, scientists from Beike Biotechnology ( http://www.beikebiotech.com/ ), China's leading stem cell research and regenerative medicine company, and Medistem, Inc. (Pink Sh